In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, highlights first-time ...

A deep learning system can accurately detect vision-threatening diabetic retinopathy, demonstrating specialist-level diagnostic performance.

Diabetic patients with high myopia have a significantly lower choroidal vascularity index (CVI) than those with diabetic retinopathy (DR), according to research published in Frontiers in Cell and ...

Ophthalmologist , Vitreoretinal Surgeon, talks about how diabetic retinopathy is caused in patients with diabetes as well as treatment and management strategies.

Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

The aim of this review is to provide a clinical update on diabetic retinopathy (DR) for the primary care physician. It should be noted, however, that diabetes can impact other sites within the eye ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

Geriatrics and Aging. 2008;11(6):333-341. Proliferative diabetic retinopathy is clinically characterized by the growth of new blood vessels that arise from the optic disc and/or retina and ...

The global Diabetic Retinopathy Market is estimated to be valued at USD 9,830 million in 2025 and is projected to reach USD 18,259.3 million by 2035, registering a compound annual growth rate (CAGR) ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) regulates abnormal blood vessel growth in the damaged retina, which ...